GL1X · GenesisL1 explorer

Research workbench

Wild-type transthyretin in complex with 2-boronic acid-1-[(1E)-2-(3- boronic ACID)ETHENYL]-4-chlorobenzene

Analyse Wild-type transthyretin in complex with 2-boronic acid-1-[(1E)-2-(3- boronic… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5U4G
Type
protein
Length
231 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
7UV
Pockets
3 · best druggability 0.30

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1166% helix, 53% strandP02766
BTransthyretinprotein1155% helix, 53% strandP02766

Ligands and binding sites

  • 7UV · (3-{(E)-2-[2-chloro-4-(hydroxyboranyl) phenyl]ethenyl}phenyl)boronic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1620.300.7516empty
2560.300.7513empty
3650.290.7317empty

Interfaces

1 interface between chains.

  • A–B · 930 Ų buried · 19 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 5U4G · Wild-type Transthyretin in complex with 2-Boronic Acid-1-[(1E)-2-(3-boronic… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.